Literature DB >> 26905187

Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative.

Annie Wang1, Malcolm Hart Squires2, Marcovalerio Melis1, George A Poultsides3, Jeffrey A Norton3, Linda X Jin4, Ryan C Fields4, Gaya Spolverato5, Timothy M Pawlik5, Konstantinos I Votanopoulos6, Edward A Levine6, Carl Schmidt7, Mark Bloomston7, Clifford S Cho8, Sharon Weber8, Russell Berman1, H Leon Pachter1, Elliot Newman1, Charles A Staley2, Shishir K Maithel2, Ioannis Hatzaras9.   

Abstract

BACKGROUND: Gastric cancer constitutes a major public health problem. This study sought to evaluate the relevance of race in gastric cancer and its prognostic effect in the overall outcomes of patients with gastric adenocarcinoma. STUDY
DESIGN: Patients who underwent curative intent resection of gastric adenocarcinoma in 8 institutions of the US Gastric Cancer Collaborative were included, from 2000 to 2012. Nonparametric descriptive statistics were used to evaluate characteristics of standard demographic data. Multivariate Cox proportional hazards regression was used to identify factors associated with recurrence-free survival and overall survival.
RESULTS: There were 1,077 patients included in the study, the majority of whom were of Caucasian race (n = 698, 68%), followed by African-American (n = 164, 15%), Asian (n = 132, 12%), Hispanic (n = 34, 3.2%), and other (n = 49, 4.5%). Clinicopathologic data were similarly distributed among the 5 groups. Mean follow-up was 27.1 months. By multivariate, stage-specific analysis, Asian race was a significant predictor of recurrence (all stages hazard ratio [HR] 0.45 95% CI [0.23, 0.97], p = 0.041) and of overall survival (all stages HR 0.35 95% CI [0.18, 0.68], p = 0.002). Recurrence-free survival was significantly increased in the Asian population compared with the non-Asian population (25th percentile: 38.6 vs 17.7 months, p = 0.0096), as was overall median survival (141 vs 38.8 months, p < 0.001).
CONCLUSIONS: Patients of Asian race undergoing curative gastrectomy for gastric adenocarcinoma appear to have a better prognosis stage for stage. Further studies are required to elucidate the underlying etiology of this phenomenon.
Copyright © 2016 American College of Surgeons. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26905187     DOI: 10.1016/j.jamcollsurg.2015.12.043

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Trends in Major Gastrectomy for Cancer: Frequency and Outcomes.

Authors:  Eric M Groh; Noorie Hyun; David Check; Theo Heller; R Taylor Ripley; Jonathan M Hernandez; Barry I Graubard; Jeremy L Davis
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population.

Authors:  René Warschkow; Matthias Baechtold; Kenneth Leung; Bruno M Schmied; Daniel P Nussbaum; Beat Gloor; Dan G Blazer Iii; Mathias Worni
Journal:  Gastric Cancer       Date:  2017-06-23       Impact factor: 7.370

3.  Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study.

Authors:  Shuairan Zhang; Yang Liu; Zihan Jiao; Zenan Li; Jin Wang; Ce Li; Xiujuan Qu; Ling Xu
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

4.  Construction of a nomogram for the prediction of prognosis in patients with resectable gastric cancer undergoing fewer than sixteen lymph node biopsies.

Authors:  Zhe Li; Hong Cen
Journal:  Onco Targets Ther       Date:  2019-09-11       Impact factor: 4.147

5.  Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.

Authors:  Changwei Lin; Bowen Yu; Mao Zhang; Yifei Chen; Liang Li; Deze Zhao
Journal:  Front Genet       Date:  2020-11-17       Impact factor: 4.599

6.  Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma.

Authors:  Hui Wang; Yao Peng; Qi Huang; Jingjing Wu; Mingjun Zhang
Journal:  Biomed Res Int       Date:  2021-03-24       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.